Steven Cohen’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Steven Cohen’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-35,000	Closed	-$764K	–	2981
2023 Q3	$764K	Buy	+35,000	New	+$876K	﹤0.01%	1411

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Steven Cohen's CERE Position: Q2 2023 in Review

Steven Cohen sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q2 2023, closing a stake of 111,400 shares — an estimated $2.72M sold.

Steven Cohen first reported a position in CERE in Q4 2020 and held it in 8 quarters. The position peaked at $30.6M in Q3 2022. 125 funds tracked by Wall St. Rank hold CERE as of Q2 2023.

Steven Cohen reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Steven Cohen sold 111,400 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q2 2023, an estimated $2.72M.
Steven Cohen first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
Steven Cohen's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $30.6M in Q3 2022.
125 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.